FDA Investigator Gayle J Gehrman
Gayle J Gehrman has conducted inspections on 9 sites in 1 countries as of 19 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
19 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gayle J Gehrman:
Alice S Tsao,
Amber D Brodas,
Amy Kim,
Amy Wyan Mai,
Andrew F Cohen,
Anna M Alexander,
Anthony R Rauert,
Arduino Frankovic,
Ashley Polizzotto,
Ayorinde O Babalola,
Camille D Monde,
Carrie E Jolly,
Christian Parra,
David J Leray,
Devina K Budhan,
Donald J Ullstrom,
Eduarda E Duran,
Evelyn Taha,
Frank A Boardwick,
Irina Gaberman,
Jane C Chen,
Jason Kwong,
Jennifer L Custodio,
John P Sakowski,
Joseph O Sullivan,
Joy P Matthias,
Juliana Falla,
Kimberley A Ricketts,
Kimberly N Garner,
Kwong P Lee,
Leena Thomas,
Lisa Mathew,
Lydia E Gonzalez,
Michele C Murray Schrade,
Nazmul Hassan,
Perez,
Peter M Trunk,
Peter R Caparelli,
Randolph R King,
Rita F Monfort,
Sarah A Meehan,
Stanley Noneze,
Tara K Carmody,
Tara K Normandin,
Thomas Cote,
Valerie Jgrecek Trinh,
Wayne J Meyer,
Yuyan Liang
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more